Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Marrone Bio Innovations Company Profile (NASDAQ:MBII)

Consensus Ratings for Marrone Bio Innovations (NASDAQ:MBII) (?)
Ratings Breakdown: 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $11.52 (346.51% upside)

Analysts' Ratings History for Marrone Bio Innovations (NASDAQ:MBII)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/4/2014Stifel NicolausLower Price TargetBuy$16.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2014ZacksDowngradeOutperform -> Neutral$6.60ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Robert W. BairdDowngradeOutperform -> Neutral$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Piper JaffrayDowngradeOverweight -> Neutral$19.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
6/30/2014Robert W. BairdInitiated CoverageOutperform$15.00ViewTweet This Rating  Share This Rating on StockTwits
6/9/2014Jefferies GroupLower Price TargetBuy$23.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013Stifel NicolausReiterated RatingBuy$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
10/3/2013Jefferies GroupBoost Price TargetBuy$17.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013Roth CapitalInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013Stifel NicolausInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013Jefferies GroupInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013Piper JaffrayInitiated CoverageBuy -> OverweightViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/31/2012 forward)
Discuss Marrone Bio Innovations